Lymphoma Rounds: Washington, D.C.

Washington Marriott Georgetown Hotel (click here for directions)
1221 22nd Street NW
Washington, D.C. 20037

Thursday, April 4, 2019
6:00 PM – 8:30 PM


ACTIVITY CHAIR

Bruce D. Cheson, MD, FACP, FAAAS
Georgetown University Hospital
Lombardi Comprehensive Cancer Center

PROGRAM AGENDA

6:00 PMRegistration and Networking Dinner Reception
6:45 PMWelcome
Piper Harmon, Lymphoma Research Foundation and
Bruce D. Cheson, MD, FACP, FAAAS, Georgetown University Hospital Lombardi Comprehensive Cancer Center
7:00 PM A Case of Mantle Cell Lymphoma
Aron Simkins, MD, George Washington University Cancer Center
Moderator
Kieron Dunleavy, MD, George Washington University Cancer Center
7:30 PMTBA
Aarthi Shenoy, MD, MedStar Washington Hospital Center
8:00 PMIbrutinib Intolerant CLL
Maryam S. Yazdy, MD, Georgetown University Hospital Lombardi Comprehensive Cancer Center
Moderator
Bruce D. Cheson, MD, FACP, FAAAS, Georgetown University Hospital Lombardi Comprehensive Cancer Center
8:30 PMAdjourn
This program is free for healthcare professionals; however, pre-registration is required. Food and refreshments will be provided for all registered participants.

Please note: Only representatives from supporting pharmaceutical companies are invited to register. If your company is interested in becoming a Lymphoma Rounds supporter please contact Piper Harmon, LRF, at pharmon@lymphoma.org.  Exhibit opportunities are also available, however, space is limited.

Companies that have secured a national exhibit sponsorship for Lymphoma Rounds must still rsvp by emailing Piper Harmon (pharmon@lymphoma.org) at least one week before the program to confirm their attendance. Otherwise, an exhibit table will not be guaranteed.

REGISTER TODAY

ABOUT THE PROGRAM
The Lymphoma Research Foundation’s Washington DC Lymphoma Rounds program provides a forum for healthcare professionals to meet on a regular basis and address issues specific to the diagnosis and treatment of their lymphoma patients. Participants will network, share best practices and learn the latest information on new therapies and advances in the management of lymphoma through interactive case studies presented by lymphoma experts in the Greater Washington DC area.

At the conclusion of this educational activity, the participant should be better able to:

  • Summarize the latest developments in lymphoma diagnosis, treatment and management.
  • Apply best practices for treating lymphoma patients.
  • Inform patients about potential clinical trial opportunities.
  • Establish a network of health care professionals who work with lymphoma patients.

Other dates in the 2018-19 Washington D.C. Rounds series:

  • Thursday, April 4, 2019

Washington DC Lymphoma Rounds Steering Committee

Georgetown University Hospital
Lombardi Comprehensive Cancer Center

Bruce D. Cheson, MD, FACP, FAAAS (chair)
George Washington University Cancer Center
Kieron Dunleavy, MD
Mitchell Smith, MD, MS
Eduardo Sotomayor, MD
MedStar Washington Hospital Center
Aarthi Shenoy, MD
National Cancer Institute
Mark Roschewski, MD
University of Virginia Cancer Center
Craig Portell, MD

Joint Providership Statement

This activity has been planned and implemented in accordance with the Accreditation Requirements and Policies of the Accreditation Council for Continuing Medical Education through the joint providership of the University of Nebraska Medical Center, Center for Continuing Education and the Lymphoma Research Foundation.

Accreditation Statement

The University of Nebraska Medical Center, Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Statement

The University of Nebraska Medical Center, Center for Continuing Education designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit (s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Sponsors
Lymphoma Research Foundation and the University of Nebraska Medical Center, Center for Continuing Education

This activity is supported by educational grants from:

AbbVie Inc., Celgene Corporation, Genentech, Novartis, Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., Seattle Genetics, Inc., TG Therapeutics, Inc. and Verastem Oncology